Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Veto of Prescription Drug…
Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB)…
BIO Statement on Resignation of FDA Commissioner…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…
BIO Launches “The Fight of Our Lives,” a National…
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…
All Press Releases
  • Show All
Search
Results
Event Tags
June 20, 2016
Regrettably, today the Supreme Court missed an opportunity in the case of Cuozzo Speed Technologies, LLC v. Lee to reign in the United States Patent and Trademark Office’s Patent Trial and Appeal Board‘s invalidation of many patents under looser…
June 15, 2016
35,700 Partnering Meetings Held During the Convention15,937 Industry Leaders Attended World's Largest Biotech Gathering
June 8, 2016
BIO and Missouri Biotechnology Association (MOBIO) commend Governor Jay Nixon for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines. 
June 8, 2016
BIO today presented Virginia Governor Terry McAuliffe with its 2016 Governor of the Year award in recognition of his leadership and commitment to strengthening the biosciences industry within Virginia. Governor McAuliffe received the award at the…
June 8, 2016
 San Francisco, CA (June 8, 2016) – Today, the Biotechnology Innovation Organization (BIO) and Parent Project Muscular Dystrophy (PPMD) released a new report, “Key Considerations for Developing and Integrating Patient Perspectives in Drug…
June 8, 2016
Today, the Biotechnology Innovation Organization (BIO) and Parent Project Muscular Dystrophy (PPMD) released a new report, “Key Considerations for Developing and Integrating Patient Perspectives in Drug Development: Examination of the Duchenne Case…
June 6, 2016
Bioscience industry contributing to U.S. economic growth and improving quality of life for patients
June 6, 2016
BIO today announced six companies have joined the Industrial & Environmental Section in the past year. The announcement was made following BIO’s Industrial & Environmental Section member meeting and election of governing board officers…
June 6, 2016
BIO is pleased to announce the election of two new Board Officers, several new Section Governing Board Chairs, and 21 new members of its Board of Directors, all voted upon at this year’s 2016 BIO International Convention.
June 2, 2016
Washington, D.C. (June 2, 2016) – The Biotechnology Innovation Organization (BIO) has announced a new partnership with Airgas, an Air Liquide company and one of the nation’s leading suppliers of industrial, medical, and specialty gases, and…